Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial

Clinical trial NCT00375622 · COMPLETED

Trial details

NCT number: NCT00375622
Sponsor: Rabin Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hereditary Hemorrhagic Telangiectasia

Start date: 2005-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.